Association between plasma lipoprotein levels and bioprosthetic valve structural degeneration

作者：Nsaibia Mohamed Jalloul; Mahmut Ablajan; Mahjoub Haifa; Dahou Abdellaziz; Bouchareb Rihab; Boulanger Marie Chloe; Despres Jean Pierre; Bosse Yohan; Arsenault Benoit J; Larose Eric; Pibarot Philippe; Mathieu Patrick^*

来源：Heart, 2016, 102(23): 1915-U90.

DOI：10.1136/heartjnl-2016-309541

Introduction Structural valve degeneration (SVD) leads to the failure of aortic valve bioprostheses. It is suspected that lipid-derived factors could play a role in SVD. We hypothesised that oxidised low-density lipoprotein (OxLDL), OxLDL/LDL, OxLDL/high-density lipoprotein (OxLDL/HDL) and proprotein convertase subtilisin/kexin 9 (PCSK9) may be associated with SVD.
Methods We included 199 patients who underwent an aortic valve replacement with a bioprosthesis and had an echocardiography follow-up to evaluate the function of the prosthesis. SVD was defined as an increase in mean transprosthetic gradient (>= 10 mm Hg) or a worsening of transprosthetic regurgitation (>= 1/3) during the follow-up.
Results After a mean follow-up of 8 +/- 3.5 years, 41 (21%) patients developed SVD. The univariate predictors of SVD were LDL (p=0.03), apolipoprotein B (p=0.01), OxLDL (p=0.02), OxLDL/HDL (p=0.009) and LDL associated with small, dense particles (LDL-C< 255) (p=0.02). In a model adjusted for covariates, only OxLDL/HDL (OR 1.49, 95% CI 1.08 to 2.07 per 10 units, p=0.01) remained associated with SVD. There was a significant interaction between OxLDL/HDL and PCSK9 on SVD (p=0.05). After adjustment, compared with patients with low OxLDL/HDL (median, < 25.4) and low PCSK9 (median, < 298 ng/mL) (referent), patients with both an elevated OxLDL/HDL ratio and PCSK9 had a higher risk of SVD (OR 2.93, 95% CI 1.02 to 9.29, p=0.04).
Conclusions OxLDL/HDL ratio is independently associated with SVD.

• 出版日期2016-12-1